Ramiro Guerrero - 08 May 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role: Director
Signature: /s/ Ramiro Guerrero
Issuer symbol: MAIA
Transactions as of: 08 May 2025
Net transactions value: +$71,000
Form type: 4
Filing time: 12 May 2025, 16:14:02 UTC
Previous filing: 08 Apr 2025
Next filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Guerrero Ramiro	Director	444 WEST LAKE STREET, SUITE 1700, CHICAGO	/s/ Ramiro Guerrero	12 May 2025	0001913253

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MAIA	Common Stock	Purchase	$30,000	+20,000	+3.5%	$1.50	588,218	08 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MAIA	Warrants	Purchase	$41,000	+20,000		$2.05	20,000	08 May 2025	Common Stock	20,000	$2.05	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.
F2	These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.